Prelude Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-48,757
| Closed | -$2.27M | – | 1367 |
|
|
2023
Q2 | $2.27M | Buy |
+48,757
| New | +$2.27M | 0.15% | 155 |
|
|
2022
Q4 | – | Sell |
-15,842
| Closed | -$321K | – | 1640 |
|
|
2022
Q3 | $321K | Buy |
15,842
+1,769
| +13% | +$35.8K | 0.01% | 821 |
|
|
2022
Q2 | $218K | Sell |
14,073
-625
| -4% | -$9.68K | 0.01% | 1063 |
|
|
2022
Q1 | $281K | Buy |
+14,698
| New | +$281K | 0.01% | 863 |
|